Octiq Sodium Chloride Eye Ointment 

Octiq by

Drug Labeling and Warnings

Octiq by is a Otc medication manufactured, distributed, or labeled by Innovus Pharmaceuticals, Inc., AMMAN PHARMACEUTICAL INDUSTRIES. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

OCTIQ- sodium chloride solution 
Innovus Pharmaceuticals, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Octiq Sodium Chloride Eye Ointment 

Active ingredients

Sodium Chloride 5%

Purpose

Hypertonicity agent

Use

For the temporary relief of corneal edema

Warnings

• For external use only

Do not use 

• except under the advice and supervision of a doctor
• if solution changes color or becomes cloudy

When using this product

• ot may cause temporary burning and irritation
• to avoid contamination, do not touch tip of container to any surface
• Replace cap after use

Stop use and ask a doctor if

• condition worsens or persists for more than 72 hours
• you experience eye pain, changes in vision, continued redness or irritation of the eye

Keep out of reach of children 

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Instill 1 or 2 drops in the affected eye(s) every 3 or 4 hours, or as directed by a doctor.

Other Information 

• store upright at 15°C-25°C (59°F-77°F)
• keep tightly closed
• serious side effects associated with use of the product may be reported to the phone number provided below

Inactive ingredients

boric acid, hypromellose, propylene glycol, purified water, sodium borate.

Hydrochloric acid and/or sodium hydroxide may be added to adjust pH.

Questions or comments?

Call 1-888-388-1774

Package/Label Principal Display Panel - Octiq

NDC: 57483-611-05

Octiq

Sodium chloride hypertonicity ophthalmic solution, 5%

Solution 5%

Sterile

preservative free

Temporary relief of corneal edema

2x 15 ml bottles

0.5 ml each

Twin Pack

OCTIQ 
sodium chloride solution

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 57483-611
Route of Administration	OPHTHALMIC

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37)	SODIUM CHLORIDE	50 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
BORIC ACID (UNII: R57ZHV85D4)
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
WATER (UNII: 059QF0KO0R)
SODIUM BORATE (UNII: 91MBZ8H3QO)
HYDROCHLORIC ACID (UNII: QTT17582CB)
SODIUM HYDROXIDE (UNII: 55X04QC32I)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 57483-611-05	2 in 1 CARTON	06/30/2022	06/30/2022
1		15 mL in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part349	06/30/2022	06/30/2022

Labeler - Innovus Pharmaceuticals, Inc. (962507187)

Establishment
Name	Address	ID/FEI	Business Operations
AMMAN PHARMACEUTICAL INDUSTRIES		534677849	manufacture(57483-611)

Revised: 12/2022

Document Id: d083d749-0434-4399-b30e-3fc3f4b43701

34390-5

Set id: e89ed520-f805-4701-89c3-69558fb38195

Version: 3

Effective Time: 20221231